In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants progressed to an advanced form of SM, incurring greater healthcare costs along the way.

Systemic mastocytosis is a rare blood disorder in which too many mast cells accumulate in various parts of the body. Advanced forms of systemic mastocytosis have more significant symptoms and in ...

Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

Cogent Biosciences, Inc. topline results for phase 2/3 studies on bezuclastinib targeting systemic mastocytosis & GIST are ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.

Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her concerns until a concerning episode made her seek out more answers.

Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...

Gastrocrom is used to treat mastocytosis in adults and in children ages 2 years and older. Note: Most of the side effects Gastrocrom can cause are also symptoms of mastocytosis, which Gastrocrom ...